Page last updated: 2024-11-05

trientine and Central Nervous System Diseases

trientine has been researched along with Central Nervous System Diseases in 3 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lannareix, V1
Basseka, H1
Catalaa, I1
Sevely, A1
Marson, F1
Manelfe, C1
Dalmau Obrador, J1
Martí-Vilalta, JL1
Aguilar Barberá, M1
River, Y1
Honigman, S1
Gomori, JM1
Reches, A1

Reviews

1 review available for trientine and Central Nervous System Diseases

ArticleYear
[Wilson's disease (hepatolenticular degeneration)].
    Medicina clinica, 1984, Jun-09, Volume: 83, Issue:2

    Topics: Adolescent; Adult; Anemia, Hemolytic; Central Nervous System Diseases; Child; Combined Modality Ther

1984

Other Studies

2 other studies available for trientine and Central Nervous System Diseases

ArticleYear
[Superficial siderosis of the central nervous system: a case report].
    Journal de radiologie, 2002, Volume: 83, Issue:12 Pt 1

    Topics: Central Nervous System Diseases; Cerebral Angiography; Chelating Agents; Chronic Disease; Female; He

2002
Superficial hemosiderosis of the central nervous system.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:5

    Topics: Astrocytoma; Central Nervous System Diseases; Cerebellar Neoplasms; Combined Modality Therapy; Ferri

1994